Stock listing
Oragenics Inc.
Selected listing: 0A64 · LSE · USD · GB
Oragenics Inc. (LSE:0A64), Health Technology. Latest release May 19, 2026: Oragenics : Investor Presentation - May 2026.
- Ticker
- LSE:0A64
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- LSE
- Currency
- USD
Latest news from Oragenics Inc.
Oragenics : Investor Presentation - May 2026
May 19, 2026
ORAGENICS PROVIDES INVESTOR UPDATE
May 18, 2026
Oragenics Signs Letter of Intent to License CardioDialysis™ Technology from Sigyn Therapeutics to Target TBI-Induced Systemic Inflammation
May 7, 2026
Oragenics Activates Second Site in Phase IIa Clinical Trial of ONP-002 for Concussion and Mild Traumatic Brain Injury.
May 5, 2026
Oragenics Reports 8 study drug doses in Phase IIa Clinical Trial of ONP-002 for Mild Traumatic Brain Injury
April 20, 2026
Research Oragenics Inc.
Alternate listings
OGEN:AMEX
US · USD
Alternate listing for Oragenics Inc.; the primary context on this page is 0A64:LSE.
OGEN:BOATS
US · USD
Alternate listing for Oragenics Inc.; the primary context on this page is 0A64:LSE.
UAV0:GETTEX
DE · EUR
Alternate listing for Oragenics Inc.; the primary context on this page is 0A64:LSE.
UAV0:MUN
DE · EUR
Alternate listing for Oragenics Inc.; the primary context on this page is 0A64:LSE.